AbbVie Inc. CDR (4AB0)
FSX
Closed
Aug 21, 2026
Day's Range
24.2052 wk Range
16.40Overview - 4AB0 - AbbVie Inc. CDR
Key Statistics
Valuation
Enterprise Value
91.52B
P/E (Trailing)
‪75.62‬
PEG Ratio
‪0.26‬
Price / Sales (TTM)
‪6.27‬
Price / Book
‪-68.61‬
EV / EBITDA
‪3.48‬
Profitability
Gross Margin
‪74.74%‬
Profit Margin
‪9.80%‬
Operating Margin
‪40.03%‬
Return on Assets
‪10.51%‬
Return on Equity
‪-129.67%‬
Ownership
Shares Outstanding
1.76B
Float
1.76B
Price stats
Beta
‪0.28‬
50-Day Avg
‪20.37‬
200-Day Avg
‪18.84‬
Dividends
Payout Ratio
‪182.95%‬
Frequency
Quarterly
Market Cap - 4AB0 - AbbVie Inc. CDR
Peers - 4AB0 - AbbVie Inc. CDR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
- 4AB0FSXAbbVie Inc. CDR404.07BMarket Cap+27.27%52-week change75.63P/E (Trailing)‪9.80%‬Profit Margin
- LLYFSXEli Lilly and Company967.12BMarket Cap+44.79%52-week change42.45P/E (Trailing)‪33.52%‬Profit Margin
- LLY0FSXEli Lilly CDR862.66BMarket Cap+42.05%52-week change37.71P/E (Trailing)‪33.52%‬Profit Margin
- JNJFSXJohnson & Johnson559.57BMarket Cap+34.23%52-week change31.59P/E (Trailing)‪21.48%‬Profit Margin
- JNJ0FSXJohnson & Johnson CDR515.60BMarket Cap+32.69%52-week change28.49P/E (Trailing)‪21.48%‬Profit Margin
- 4ABFSXAbbVie Inc.400.95BMarket Cap+21.11%52-week change74.64P/E (Trailing)‪9.80%‬Profit Margin
- RHOFSXRoche Holding AG323.48BMarket Cap+28.47%52-week change24.76P/E (Trailing)‪19.60%‬Profit Margin
Profile Summary - 4AB0 - AbbVie Inc. CDR
About
AbbVie Inc. CDR is a Canadian Depositary Receipt that provides Canadian investors with exposure to AbbVie Inc., a research-based biopharmaceutical company, trading in Canadian dollars with a currency hedge to minimize foreign exchange risk. AbbVie Inc. engages in the discovery, development, manufacturing, and sale of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
